Atlas Trials

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Clinical trial NCT00853697 · COMPLETED

Trial details

NCT number
NCT00853697
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerCastration-resistant, Metastatic
Start date
2009-03-01
Primary completion
2012-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.